References
- Zheng ZJ, Croft JB, Giles WH, MensahGA. Sudden cardiac death in the United States, 1989 to 1998. Circulation104(18), 2158–2163 (2001).
- Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J. Cardiovasc. Electrophysiol.12(3), 369–381(2001).
- Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med.352(3), 225–237(2005).
- Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med.346(12), 877–883 (2002).
- Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation69(2), 250–258 (1984).
- Mukharji J, Rude RE, Poole WK et al. Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am. J. Cardiol.54(1), 31–36 (1984).
- Stecker EC, Vickers C, Waltz J et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J. Am. Coll. Cardiol.47(6), 1161–1166 (2006).
- Every N, Hallstrom A, McDonald KM et al. Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease. Am. Heart J.144(3), 390–396 (2002).
- Zimetbaum PJ. A 59-year-old man considering implantation of a cardiac defibrillator. JAMA297(17),1909–1916 (2007).
- Hernandez AF, Fonarow GC, Liang L et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA298(13),1525–1532 (2007).
- Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N. Engl. J. Med.353(14),1471–1480 (2005).
- Mushlin AI, Hall WJ, Zwanziger J et al. The cost–effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Circulation97(21), 2129–2135 (1998).
- Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J. Am. Coll. Cardiol.46(1), 75–82 (2005).
- Narayan SM. T-wave alternans and the susceptibility to ventricular arrhythmias. J. Am. Coll. Cardiol.47(2), 269–281 (2006).
- Hering HE. Experimentelle Studie an Säugetieren über das Elektrokardiogramm. Zeitschrift f.exp. Pathologie u.Therapie.7, 363–378 (1909).
- Schwartz PJ, Malliani A.Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q–T syndrome. Am. Heart J.89(1), 45–50 (1975).
- Puletti M, Curione M, Righetti G, Jacobellis G. Alternans of the ST segment and T wave in acute myocardial infarction. J. Electrocardiol.13(3), 297–300 (1980).
- Joyal M, Feldman RL, Pepine CJ. ST-segment alternans during percutaneous transluminal coronary angioplasty. Am. J. Cardiol.54(7), 915–916 (1984).
- Kavesh NG, Shorofsky SR, Sarang SE, Gold MR. Effect of heart rate on T wave alternans. J. Cardiovasc. Electrophysiol.9(7), 703–708 (1998).
- Kaufman ES, Mackall JA, Julka B, Drabek C, Rosenbaum DS. Influence of heart rate and sympathetic stimulation on arrhythmogenic T wave alternans. Am. J. Physiol. Heart Circ. Physiol.279(3), H1248–H1255 (2000).
- Bloomfield DM, Hohnloser SH, Cohen RJ. Interpretation and classification of microvolt T wave alternans tests. J. Cardiovasc. Electrophysiol.13(5), 502–512 (2002).
- Rosenbaum DS, Albrecht P, Cohen RJ. Predicting sudden cardiac death from T wave alternans of the surface electrocardiogram: promise and pitfalls. J. Cardiovasc. Electrophysiol.7(11), 1095–111 (1996).
- Hohnloser SH, Klingenheben T, Zabel M, Li YG, Albrecht P, Cohen RJ. T wave alternans during exercise and atrial pacing in humans. J. Cardiovasc. Electrophysiol.8(9), 987–993 (1997).
- Rashba EJ, Osman AF, MacMurdy K et al. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J. Cardiovasc. Electrophysiol.13(9), 845–850 (2002).
- Bloomfield DM, Ritvo BS, Parides MK, Kim MH. The immediate reproducibility of T wave alternans during bicycle exercise. Pacing Clin. Electrophysiol.25(8), 1185–1191 (2002).
- Molon G, Costa A, Bertolini L et al. Relationship between abnormal microvolt T wave alternans and poor glycemic control in Type-2 diabetic patients. Pacing Clin. Electrophysiol.30(10), 1267–1272 (2007).
- Rashba EJ, Osman AF, MacMurdy K et al. Influence of QRS duration on the prognostic value of T wave alternans. J. Cardiovasc. Electrophysiol.13(8), 770–775 (2002).
- Kaufman ES, Bloomfield DM, Steinman RC et al. ‘Indeterminate’ microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J. Am. Coll. Cardiol.48(7), 1399–1404 (2006).
- Chan PS, Bartone C, Booth T, Kereiakes D, Chow T. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal. Am. Heart J.153(4), 523–529 (2007).
- Nearing BD, Verrier RL. Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J. Appl. Physiol.92(2), 541–549 (2002).
- Exner DV, Kavanagh KM, Slawnych MP et al. Noninvasive Risk Assessment Early After a Myocardial Infarction - The REFINE Study. J. Am. Coll. Cardiol.50(24), 2275–2284 (2007).
- Nieminen T, Lehtimaki T, Viik J et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. Eur. Heart J.28(19), 2332–2337 (2007).
- Rashba EJ, Cooklin M, MacMurdy K et al. Effects of selective autonomic blockade on T-wave alternans in humans. Circulation105(7), 837–842 (2002).
- Klingenheben T, Gronefeld G, Li YG, Hohnloser SH. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. J. Am. Coll. Cardiol.38(7), 2013–2019 (2001).
- Kop WJ, Krantz DS, Nearing BD et al. Effects of acute mental stress and exercise on T-wave alternans in patients with implantable cardioverter defibrillators and controls. Circulation109(15), 1864–1869 (2004).
- Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation106(14), 1800–1805 (2002).
- Verrier RL, Nearing BD, La Rovere MT et al. Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J. Cardiovasc. Electrophysiol.14(7), 705–711(2003).
- Muller JE. Circadian variation in cardiovascular events. Am. J. Hypertens.12(2 Pt 2), 35S–42S(1999).
- Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical Alternans and Vulnerability to Ventricular Arrhythmias. N. Engl. J. Med.330(4), 235–241 (1994).
- Buxton AE, Lee KL, DiCarlo L et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med.342(26), 1937–1945 (2000).
- Ikeda T, Sakata T, Takami M et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J. Am. Coll. Cardiol.35(3), 722–730 (2000).
- Klingenheben T, Zabel M, D’Agostino RB, Cohen RJ, Hohnloser SH. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet356(9230), 651–652 (2000).
- Hohnloser SH, Ikeda T, Bloomfield DM, Dabbous OH, Cohen RJ. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet362(9378), 125–126 (2003).
- Bloomfield DM, Steinman RC, Namerow PB et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation110(14), 1885–1889 (2004).
- Costantini O, Rosenbaum DS. ABCD (Alternans Before Cardioverter Defibrillator). Clin. Cardiol.30, 97–100 (2007).
- Bloomfield DM, Bigger JT, Steinman RC et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J. Am. Coll. Cardiol.47(2), 456–463 (2006).
- Chow T, Kereiakes DJ, Bartone C et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J. Am. Coll. Cardiol.47(9), 1820–1827 (2006).
- Chow T, Kereiakes DJ, Bartone C et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J. Am. Coll. Cardiol.49(1), 50–89 (2007).
- Chan PS, Stein K, Chow T et al. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. J. Am. Coll. Cardiol.48(1), 112–121 (2006).
- Cantillon D, Stein KM, Markowitz SM et al. Predictive value of microvolt T wave alternans in patients with left ventricular dysfunction. J. Am. Coll. Cardiol.50, 166–173 (2007).
- Salerno-Uriarte JA, De Ferrari GM, Klersy C et al. Prognostic Value of T-Wave Alternans in Patients With Heart Failure Due to Nonischemic Cardiomyopathy: Results of the ALPHA Study. J. Am. Coll. Cardiol.50(19), 1896–1904 (2007).
- Grimm W, Christ M, Bach J, Muller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation108(23), 2883–2891 (2003).
- Gold MR, Ensley D, Chilson D et al. T-wave alternans SCD-HeFT study: primary events analysis (abstract). Ciculation114(Suppl. II), 428–429 (2006).
- Chow T, Kereiakes DJ, Onufer J et al. Primary results from the microvolt T wave alternans testing for risk stratification of post MI patients (MASTER I) Trial (abstract). Ciculation116(22), 2631 (2007).
- Ellenbogen KA, Levine JH, Berger RD et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Ciculation113(6), 776–782 (2006).
- Connolly SJ. Use and misuse of surrogate outcomes in arrhythmia trials. Circulation113(6), 764–766 (2006).
- Walker ML, Rosenbaum DS. Repolarization alternans: implications for the mechanism and prevention of sudden cardiac death. Cardiovasc. Res.57(3), 599–614 (2003).
- Rashba EJ, Osman AF, MacMurdy K et al. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J. Cardiovasc. Electrophysiol.15(2), 170–176 (2004).
- Ikeda T, Yoshino H, Suqi K et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study. J. Am. Coll. Cardiol.48(11), 2268–2274 (2006).
- Exner DV, Kavanagh KM, Slawnych MP et al. Non-invasive risk assessment early after a myocardial infarction the REFINE study. J. Am. Coll. Cardiol.50(24), 2275–2284 (2007).
- Hohnloser S. Oral Abstract Presentation. HRS Scientific Sessions (2008).
- Sweeney MO, Ruetz LL, Belk P, Mullen TJ, Johnson JW, Sheldon T. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? J. Am. Coll. Cardiol.50(7), 614–622 (2007).
- Bigger JT, Kleiger RE. Individualizing decisions for patients with prophylactic implantable cardiac defibrillators subject to device advisories: a commentary. Am. J. Cardiol.98(9), 1291–1293 (2006).
- Personal communications – Marketing and research division, Medtronic Inc. (2008).